Abstract: The invention relates to a new non-invasive test making it possible to detect infection by the SARS-CoV-2 virus in a patient, using values of Apolipoprotein A1 alone or in combination with other markers.
Type:
Grant
Filed:
May 26, 2021
Date of Patent:
December 2, 2025
Assignees:
BIOPREDICTIVE, ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS
Abstract: The present invention relates to new methods for assessing the risk of a patient, in particular with chronic liver disease, to develop primary liver cancer over time, using functions combining blood biochemical markers.
Type:
Application
Filed:
June 10, 2025
Publication date:
October 2, 2025
Applicants:
BIOPREDICTIVE, ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
Abstract: The present invention relates to new methods for assessing the risk of a patient, in particular with chronic liver disease, to develop primary liver cancer over time, using functions combining blood biochemical markers.
Type:
Grant
Filed:
October 15, 2018
Date of Patent:
July 15, 2025
Assignees:
BIOPREDICTIVE, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
Abstract: The present invention relates to new methods for assessing prognosis of recovery of DILI in a patient, combining measurement of serum markers through a logistic function that doesn't include bilirubin and transaminases (AST and ALT) markers.
Type:
Grant
Filed:
March 6, 2018
Date of Patent:
April 23, 2024
Assignees:
BIOPREDICTIVE, ASSISTANCE PUBLIQUE -HOPITAUX DE PARIS
Abstract: The present invention relates to a new diagnosis method in the field of hepatology, combining measurement of serum markers and of liver elasticity.
Type:
Grant
Filed:
November 30, 2012
Date of Patent:
February 5, 2019
Assignees:
ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, BIOPREDICTIVE
Abstract: The present invention relates to a new diagnosis method in the field of hepatology, combining measurement of serum markers and of liver elasticity.
Type:
Application
Filed:
November 30, 2012
Publication date:
November 6, 2014
Applicants:
Assistance Publique - Hôpitaux de Paris, Biopredictive